Financial Shenanigans

The Forensic Verdict

SpaceX scores 60 / 100 — Elevated on our forensic risk scale. The S-1 financials are clean of any restatement or auditor finding, but the file carries an unusually thick stack of structural red flags for a company in IPO registration: a self-disclosed inability to rule out a material weakness, an incentive metric for the CFO that was switched from free cash flow to Adjusted EBITDA only weeks before the filing, more than $20B of related-party AI infrastructure lease obligations involving a sitting board member's firm, a controlled-company exemption that strips the independent compensation/nominating committee, and an Adjusted EBITDA definition that excludes items recurring in every period shown. Offsetting evidence is meaningful: DSO is short and stable, no auditor change or qualification, no SEC enforcement action, and reported cash on hand is verifiable. The single fact that would most change the grade is whether the post-IPO Section 404 attestation by PricewaterhouseCoopers — auditor of record since 2012 — comes back clean and without remediated material weaknesses.

Shenanigans Scorecard

Breeding Ground

The conditions that historically amplify accounting risk — single-shareholder control, related-party density, weak independent oversight, recurring-charge optics — are all present at investor-facing strength. None of this is concealed: the S-1 is admirably explicit. But the package as filed reads like a company designed to maximize the founder's reporting discretion under the controlled-company exemption.

The most consequential single finding is the January 4, 2026 amendment to the CFO's option vesting. Switching from free cash flow to Adjusted EBITDA, weeks before SpaceX filed an S-1 whose CFO sets the non-GAAP definition, ties the incentive to a measure the same CFO defines and reconciles. The same Adjusted EBITDA strips out share-based compensation that grew 148% year over year and interest expense on $22.9B of debt — both real cash costs.

Earnings Quality

Top line is real, but profit and cash-flow optics depend on a small number of accounting choices and one large non-operating item. The xAI common-control combination means historical periods you read in this S-1 are not the periods that were originally reported — that materially limits how much weight to put on year-over-year trend lines.

Revenue vs. accounts receivable

Revenue grew 33% in FY2025 against receivables growth of 50% — a 17 pp gap. The absolute level (DSO at ~26 days on a trailing-quarter average) is not alarming for a Falcon/Starshield contract mix, but the gap merits monitoring because Launch & Development contracts moved from 32% to 37% of Space revenue in 2024 → 2025, which extends the period over which work is performed but not yet billed.

GAAP vs Adjusted EBITDA

The Adjusted EBITDA bridge adds back: depreciation and amortization ($6.7B in 2025), SBC ($1.95B), impairment ($38M), restructuring ($487M), interest expense ($1.95B), tax provision ($718M), and Other expense ($177M). Three of these are recurring annual events — restructuring, impairment, and SBC each appear in every period — which means "non-recurring" is the wrong framing.

Recurring items framed as one-time

The FY2023 stack is dominated by the $3.775B intangible impairment that wrote off the legacy Twitter brand following the rebrand to X — recognized in 2023 because xAI/X is being retrospectively combined for all periods presented. That single charge accounts for the year's $4.6B net loss almost in full. Reading FY2023 as a normal operating year is misleading; reading FY2024's modest net income as an inflection is misleading the other direction.

Capex versus depreciation — a deferral pipeline

Capex / depreciation ran 3.1x in FY2025. Two mechanisms convert current cash costs into deferred income-statement charges. First, Starlink launch costs are capitalized into property, plant and equipment (disclosed accounting policy), which keeps Connectivity COGS flat while the constellation expands. Second, management states that at Starship commercialization, "Starship costs generally will be capitalized and then depreciated in cost of revenue of the segment associated with the payload delivered" — flipping ~$3B of current Space research and development from immediate expense to deferred depreciation in 2026/2027. Both moves are GAAP-compliant. Both will produce a mechanical, non-economic step-up in operating margin.

Earnings quality at a glance

Cash Flow Quality

Operating cash flow looks strong at $6.785B in FY2025, but a meaningful share of it is working-capital-funded and reverses in Q1 2026. Free cash flow is deeply negative and would remain so even adjusting for the heaviest known one-offs.

Accounts payable expanded from $4.4B to $11.8B over FY2025 — a $7.4B increase, or 167%. In Q1 2026 AP fell back $1.8B to $10.0B. Management attributes the FY2025 AP build to "timing of payments" as infrastructure expanded; consistent with extended payment terms to vendors during the COLOSSUS II ramp. This is the single largest reason FY2025 CFO looked strong. It is not a recurring source.

CFO and FCF versus net income

Three-year totals: net loss of -$8.77B, CFO of +$17.08B, and free cash flow of -$19.23B. The big gap between CFO and FCF is the capex programme — $36.3B over three years. There is no path under any current line item where SpaceX self-funds Starship + Starlink V3 + COLOSSUS II out of operating cash. Financing cash flow tells the same story: equity issuance of $13.1B in FY2024 and $18.8B in FY2025; debt proceeds of $16.1B in FY2025 net of $6.9B repayments. Reported cash on hand has been recapitalized by issuance, not earned.

Sustainability-adjusted CFO

Stripping the AP/working-capital lifeline and the deferred-tax provision flip yields roughly $3.9B of sustainable operating cash, against $20.7B of capex. The Adjusted EBITDA framing of $6.6B is roughly twice the sustainable cash-generative capacity of the business at current investment intensity.

Free cash flow after acquisitions

xAI was acquired in a stock-only common-control transaction in February 2026 and does not appear as a cash outflow in investing activities. EchoStar spectrum acquisition ($19.6B; $11.1B equity + up to $8.5B cash) is signed but not closed and is expected to close in November 2027 — that drains cash post-close.

Metric Hygiene

Three management-emphasized metrics deserve special scrutiny: Adjusted EBITDA, Segment Adjusted EBITDA, and the metrics that have new definitions in this S-1.

What to Underwrite Next

The forensic risk is best understood as a valuation-haircut + position-sizing limiter combination, not a thesis breaker. The underlying space and connectivity businesses are real, growing, and cash-generative on an operating basis. But the reported numbers are not yet a clean reflection of economic reality, and the governance structure deliberately preserves the founder's flexibility to keep them that way.

Five line items to track every quarter

Disclosures that would change the verdict

Decision

A long-only fund underwriting at trillion-dollar-plus IPO valuations should price in a meaningful margin of safety on three vectors. First, Adjusted EBITDA is the wrong multiple anchor — apply the headline multiple to a sustainable-CFO proxy at roughly half the reported figure, then subtract the capital intensity needed to keep Connectivity and AI alive. Second, the CFO incentive switch from FCF to Adjusted EBITDA combined with the controlled-company exemption means the metric that drives executive economics is also the metric the executives can define — a position-sizing limiter, not a thesis breaker. Third, related-party scale will compound as Macrohard, Terafab, and orbital-AI compute monetization ramp; build a 5–10% valuation haircut for related-party drag until SpaceX establishes an independent committee with public pricing controls. Pulling all of this together, the forensic work belongs in valuation discipline and sizing, not in a kill switch.